Tonix Pharmaceuticals stock halted ahead of FDA approval news
Investing.com - International General Insurance (NASDAQ: IGIC) reported second quarter EPS of $0.770, $0.17 better than the analyst estimate of $0.600. Revenue for the quarter came in at $115M versus the consensus estimate of $133.8M.
International General Insurance’s stock price closed at $23.42. It is up 1.740% in the last 3 months and up 46.190% in the last 12 months.
International General Insurance saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See International General Insurance’s stock price’s past reactions to earnings here.
According to InvestingPro, International General Insurance’s Financial Health score is "good performance".
Check out International General Insurance’s recent earnings performance, and International General Insurance’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar